Skip to main content
Clinical Trials/NCT05967845
NCT05967845
Completed
Not Applicable

Platelet Rich Fibrin Augmented Tympanoplasty Versus Cartilage Tympanoplasty: a Randomized Clinical Trial

Mansoura University1 site in 1 country156 target enrollmentJanuary 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Suppurative Otitis Media
Sponsor
Mansoura University
Enrollment
156
Locations
1
Primary Endpoint
Healing rate, or graft take rate.
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study was performed to compare healing and hearing outcomes of two tympanoplasty techniques, performed for patients with total or subtotal tympanic membrane perforations. The first group underwent temporalis fascia tympanoplasty, augmented with platelet rich fibrin, while the second group underwent cartilage tympanoplasty. preoperative data, operative techniques, and postoperative outcomes were analyzed.

Detailed Description

Two groups are included. In the platelet rich fibrin augmented tympanoplasty group, a piece of temporalis fascia is harvested and used as a graft material. A layer of platelet rich fibrin is added to improve healing process. In the cartilage tympanoplasty group, a piece of cartilage is harvested from the patient concha and used for grafting. Both groups will be compared in terms of healing and hearing. Healing is considered successful if an intact tympanic membrane is achieved withing 12 weeks follow up period. Hearing outcomes are analyzed by comparing the preoperative pure tone audiometry values with the postoperative values.

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
December 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hisham Ebada

Assistant Professor

Mansoura University

Eligibility Criteria

Inclusion Criteria

  • Adults patients older than 18 years.
  • Chronic suppurative otitis media mucosal type with total or subtotal perforation.
  • Inactive for 3 months.

Exclusion Criteria

  • Recurrent perforation after previous tympanoplasty.
  • Active inflammation of middle ear.
  • Chronic suppurative otitis media epithelial type.
  • Ossicular disruption or fixation diagnosed intraoperatively.
  • Immunocompromised patients including uncontrolled diabetics, chronic liver and kidney diseases.

Outcomes

Primary Outcomes

Healing rate, or graft take rate.

Time Frame: 12 weeks

Closure of the tympanic membrane perforation. An intact tympanic membrane without residual perforation is considered as adequate healing and successful outcome.

Secondary Outcomes

  • Hearing outcomes(12 weeks)

Study Sites (1)

Loading locations...

Similar Trials